Type: device
Status: Available (not FDA-cleared for medical decisions)
Developer: PreEvnt
Non-invasive glucose monitoring through breath analysis. Debuted at CES 2026. Smartphone-connected with real-time readings. No needles or sensors required.
Analyzes volatile organic compounds in exhaled breath to estimate blood glucose levels
Year: 2026